Clinical Trial: Adding Dexmedetomidine to Mannitol to Attenuate the Increase of Intracranial Pressure
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Dexmedetomidine
Study Type: INTERVENTIONAL
Official Title: Adding Dexmedetomidine to Mannitol to Attenuate the Increase of Intracranial Pressure
Brief Summary:
Dexmedetomidine is a potent alpha-2 adrenergic receptor agonist.In addition, dexmedetomidine-induced stimulation of the postsynaptic alpha-2 adrenergic receptor on the cerebral blood vessels can cause cerebral vasoconstriction and decrease cerebral blood flow
Read more